Arginase Deficiency Clinical Trials
A listing of Arginase Deficiency medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
California
Stanford
Palo Alto California
A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102
District of Columbia
Children’s National
Washington District of Columbia
A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102
Florida
University of Florida
Gainesville Florida
A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102
Michigan
Children’s Hospital of Michigan
Detroit Michigan
A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102
New York
Mt. Sinai
New York New York
A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102
Pennsylvania
Children’s Hospital of Pittsburgh
Pittsburgh Pennsylvania
A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102
Texas
University of Texas Southwestern
Dallas Texas
A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102
Utah
University of Utah
Salt Lake City Utah
A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102
Washington
Seattle Children’s Hospital
Seattle Washington
A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102
Canada
SickKids
Toronto International
A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102
